Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial

Overview of attention for article published in Neuro-Oncology, July 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 537 followers.

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wid... http://t.co/sSBDLa6gS6

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.